Cutaneous sarcoidosis: Updates in the pathogenesis

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 7, 2010, Pages 747-755

  Ali, M M ^a   Atwan, A A ^a   Gonzalez, M L ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Human leukocyte antigens; Immunopathogenesis; Mycobacteria; Propionibacteria; Sarcoidosis

Indexed keywords

CELLULAR IMMUNITY; CUTANEOUS SARCOIDOSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIACEAE; REVIEW; SARCOIDOSIS; TH1 CELL; ENVIRONMENTAL EXPOSURE; GENETICS; PATHOLOGY; SKIN DISEASES;

ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; SARCOIDOSIS; SKIN DISEASES;

EID: 77953183544     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03517.x     Document Type: Review

References (107)

1. Moller DR. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc 2007 4 : 465 468.
2. Statement on sarcoidosis. Am J Respir Crit Care Med 1999 160 : 736 755.
3. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001 18 : 56S 68S.
4. Fernandez-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol 2007 25 : 276 287.
5. English JC, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol 2001 44 : 725 743.
6. Tchernev G. Cutaneous sarcoidosis: the 'great imitator': etiopathogenesis, morphology, differential diagnosis, and clinical management. Am J Clin Dermatol 2006 7 : 375 382.
7. Tchernev G, Patterson JW, Nenoff P et al. Sarcoidosis of the skin - a dermatological puzzle: important differential diagnostic aspects and guidelines for clinical and histopathological recognition. J Eur Acad Dermatol Venereol 2009 [Epub ahead of print]
8. Elgart ML. Cutaneous sarcoidosis: definitions and types of lesions. Clin Dermatol 1986 4 : 35 45.
9. McGrath DS, Daniil Z, Foley P et al. Epidemiology of familial sarcoidosis in the UK. Thorax 2000 55 : 751 754.
10. Sverrild A, Backer V, Kyvik KO et al. Heredity in sarcoidosis - a registry-based twin study. Thorax 2008 63 : 894 896.
11. Rybicki BA, Kirkey KL, Major M et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001 153 : 188 193.
12. ACCESS Research Group. Design of a case control etiologic study of sarcoidosis (ACCESS). J Clin Epidemiol 1999 52 : 1173 1186.
13. Schurmann M, Lympany PA, Reichel P et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000 162 : 861 864.
14. Schurmann M, Reichel P, Muller-Myhsok B et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001 164 : 840 846.
15. Valentonyte R, Hampe J, Huse K et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005 37 : 357 364.
16. Gray-McGuire C, Sinha R, Iyengar S et al. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet 2006 120 : 420 430.
17. Iannuzzi MC, Iyengar SK, Gray-McGuire C et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005 6 : 509 518.
18. Baughman RP, Lower EE, Du Bois R. Sarcoidosis. Lancet 2003 361 : 1111 1118.
19. Rossman MD, Thompson B, Frederick M et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003 73 : 720 735.
20. Rybicki BA, Maliarik MJ, Poisson LM et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med 2003 167 : 444 449.
21. Swider C, Schnittger L, Bogunia-Kubik K et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999 10 : 143 146.
22. Grutters JC, Sato H, Pantelidis P et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 2002 165 : 1119 1124.
23. Hutyrova B, Pantelidis P, Drabek J et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002 165 : 148 151.
24. Rybicki BA, Maliarik MJ, Malvitz E et al. The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans. Hum Immunol 1999 60 : 867 874.
25. Niimi T, Tomita H, Sato S et al. Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 1999 160 : 1107 1109.
26. Maliarik MJ, Chen KM, Sheffer RG et al. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol 2000 22 : 672 675.
27. Hizawa N, Yamaguchi E, Furuya K et al. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 1999 159 : 2021 2023.
28. Petrek M, Drábek J, Kolek V et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000 162 : 1000 1003.
29. Spagnolo P, Renzoni EA, Wells AU et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 2003 168 : 1162 1166.
30. Maliarik M, Rybicki B, Malvitz E et al. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 1998 158 : 1566 1570.
31. Tahir M, Sharma S, Ashraf S et al. Angiotensin converting enzyme genotype affects development and course of sarcoidosis in Asian Indians. Sarcoidosis Vasc Diffuse Lung Dis 2007 24 : 106 112.
32. Schürmann M, Reichel P, Müller-Myhsok B et al. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Intern Med 2001 249 : 77 83.
33. Sharma S, Ghosh B, Sharma SK. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 2008 151 : 251 259.
34. Lopez-Campos JL, Rodriguez-Rodriguez D, Rodriguez-Becerra E et al. Cyclooxygenase-2 polymorphisms confer susceptibility to sarcoidosis but are not related to prognosis. Respir Med 2009 103 : 427 433.
35. Hofmann S, Franke A, Fischer A et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008 40 : 1103 1106.
36. Macaron NC, Cohen C, Chen SC et al. gli-1 Oncogene is highly expressed in granulomatous skin disorders, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica diabeticorum. Arch Dermatol 2005 141 : 259 262.
37. Cogrel O, Doutre M, Marlière V et al. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol 2002 146 : 320 324.
38. Martin WJ, Iannuzzi MC, Gail DB et al. Future directions in sarcoidosis research: summary of an NHLBI Working Group. Am J Respir Crit Care Med 2004 170 : 567 571.
39. Hosoda Y, Sasagawa S, Yasuda N. Epidemiology of sarcoidosis: new frontiers to explore. Curr Opin Pulm Med 2002 8 : 424 428.
40. Astudillo L, Soler V, Sailler L et al. Bilateral exophthalmos revealing a case of husband and wife sarcoidosis. Am J Med 2006 119 : e7 e8.
41. Parkes SA, Baker SB, Bourdillon RE et al. Epidemiology of sarcoidosis in the Isle of man-1: a case controlled study. Thorax 1987 42 : 420 426.
42. Sipahi Demirkok S, Basaranoglu M, Dervis E et al. Analysis of 87 patients with Lofgren's syndrome and the pattern of seasonality of subacute sarcoidosis. Respirology 2006 11 : 456 461.
43. Izbicki G, Chavko R, Banauch GI et al. World Trade Center "Sarcoid-Like" granulomatous pulmonary disease in New York City Fire Department Rescue Workers. Chest 2007 131 : 1414 1423.
44. Prezant DJ, Dhala A, Goldstein A et al. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 1999 116 : 1183 1193.
45. Centers for Disease Control and Prevention (CDC). Sarcoidosis among U.S. Navy Enlisted Men, 1965-1993. MMWR Morb Mortal Wkly Rep 1997 46 : 539 543.
46. Jajosky P. Sarcoidosis diagnoses among U.S. military personnel:: trends and ship assignment associations. Am J Prev Med 1998 14 : 176 183.
47. Kucera GP, Rybicki BA, Kirkey KL et al. Occupational risk factors for sarcoidosis in African-American siblings. Chest 2003 123 : 1527 1535.
48. Newman LS, Rose CS, Bresnitz EA et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 170 : 1324 1330.
49. Heyll A, Meckenstock G, Aul C et al. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 1994 14 : 161 164.
50. Burke WM, Keogh A, Maloney PJ et al. Transmission of sarcoidosis via cardiac transplantation. Lancet 1990 336 : 1579.
51. Kreider ME, Christie JD, Thompson B et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005 128 : 207 215.
52. Richter E, Greinert U, Kirsten D et al. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med 1996 153 : 375 380.
53. Vokurka M, Lecossier D, du Bois RM et al. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 1997 156 : 1000 1003.
54. Fité E, Fernández-Figueras MT, Prats R et al. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration 2006 73 : 20 26.
55. el-Zaatari FA, Naser SA, Markesich DC et al. Identification of Mycobacterium avium complex in sarcoidosis. J Clin Microbiol 1996 34 : 2240 2245.
56. Marcoval J, Benitez MA, Alcaide F et al. Absence of ribosomal RNA of Mycobacterium tuberculosis complex in sarcoidosis. Arch Dermatol 2005 141 : 57 59.
57. Song Z, Marzilli L, Greenlee BM et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005 201 : 755 767.
58. Abe C, Iwai K, Mikami R et al. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg [A] 1984 256 : 541 547.
59. Ichiyasu H, Suga M, Matsukawa A et al. Functional roles of MCP-1 in Propionibacterium acnes-induced, T cell-mediated pulmonary granulomatosis in rabbits. J Leukoc Biol 1999 65 : 482 491.
60. Ishige I, Usui Y, Takemura T et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999 354 : 120 123.
61. Ebe Y, Ikushima S, Yamaguchi T et al. Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000 17 : 256 265.
62. Eishi Y, Suga M, Ishige I et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 2002 40 : 198 204.
63. Gazouli M, Ikonomopoulos J, Trigidou R et al. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 2002 40 : 3060 3063.
64. Yamada T, Eishi Y, Ikeda S et al. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol 2002 198 : 541 547.
65. Nishiwaki T, Yoneyama H, Eishi Y et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 2004 165 : 631 639.
66. Ishige I, Eishi Y, Takemura T et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005 22 : 33 42.
67. Martens H, Zollner B, Zissel G et al. Anti-Borrelia burgdorferi immunoglobulin seroprevalence in pulmonary sarcoidosis: a negative report. Eur Respir J 1997 10 : 1356 1358.
68. Blasi F, Rizzato G, Gambacorta M et al. Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens. Eur Respir J 1997 10 : 2609 2611.
69. Nilsson K, Pahlson C, Lukinius A et al. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis 2002 185 : 1128 1138.
70. Planck A, Eklund A, Grunewald J et al. No serological evidence of Rickettsia helvetica infection in Scandinavian sarcoidosis patients. Eur Respir J 2004 24 : 811 813.
71. Di Alberti L, Piatteli A, Artese L et al. Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997 350 : 1655 1661.
72. Belec L, Mohamed AS, Lechapt-Zalcman E et al. Lack of HHV-8 DNA sequences in sarcoid tissues of French patients. Chest 1998 114 : 948 949.
73. Lebbé C, Agbalika F, Flageul B et al. No evidence for a role of human herpesvirus type 8 in sarcoidosis: molecular and serological analysis. Br J Dermatol 1999 141 : 492 496.
74. Maeda H, Niimi T, Sato S et al. Human herpesvirus 8 is not associated with sarcoidosis in Japanese patients. Chest 2000 118 : 923 927.
75. Knoell KA, Hendrix JD Jr., Stoler MH et al. Absence of human herpesvirus 8 in sarcoidosis and Crohn disease granulomas. Arch Dermatol 2005 141 : 909 910.
76. Bonnet F, Morlat P, Dubuc J et al. Sarcoidosis-associated hepatitis C virus infection. Dig Dis Sci 2002 47 : 794 796.
77. Tsimpoukas F, Goritsas C, Papadopoulos N et al. Sarcoidosis in untreated chronic hepatitis C virus infection. Scand J Gastroenterol 2004 39 : 401 403.
78. Noor A, Knox KS. Immunopathogenesis of sarcoidosis. Clin Dermatol 2007 25 : 250 258.
79. Du Bois RM, Kirby M, Balbi B et al. T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor. Am Rev Respir Dis 1992 145 : 1205 1211.
80. Wahlstrom J, Katchar K, Wigzell H et al. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am J Respir Crit Care Med 2001 163 : 115 121.
81. Fehrenbach H, Zissel G, Goldmann T et al. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur Respir J 2003 21 : 421 428.
82. Suga M, Iyonaga K, Ichiyasu H et al. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 1999 14 : 376 382.
83. Moller DR, Forman JD, Liu MC et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996 156 : 4952 4960.
84. Greene CM, Meachery G, Taggart CC et al. Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol 2000 165 : 4718 4724.
85. Ota M, Amakawa R, Uehira K et al. Involvement of dendritic cells in sarcoidosis. Thorax 2004 59 : 408 413.
86. Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol 2005 141 : 865 868.
87. Alazemi S, Campos MA. Interferon-induced sarcoidosis. Int J Clin Pract 2006 60 : 201 211.
88. Goldberg HJ, Fiedler D, Webb A et al. Sarcoidosis after treatment with interferon-alpha: a case series and review of the literature. Respir Med 2006 100 : 2063 2068.
89. Trevenzoli M, Cattelan AM, Marino F et al. Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad Med J 2003 79 : 535 538.
90. Logan TF, Bensadoun ES. Increased disease activity in a patient with sarcoidosis after high dose interleukin 2 treatment for metastatic renal cancer. Thorax 2005 60 : 610 611.
91. Naccache J-M, Antoine M, Wislez M et al. Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med 1999 159 : 2009 2013.
92. Blanche P, Gombert B, Rollot F et al. Sarcoidosis in a patient with acquired immunodeficiency syndrome treated with interleukin-2. Clin Infect Dis 2000 31 : 1493 1494.
93. Bianco A, Spiteri MA. Peripheral anergy and local immune hyperactivation in sarcoidosis: a paradox or birds of a feather. Clin Exp Immunol 1997 110 : 1 3.
94. Mathew S, Bauer KL, Fischoeder A et al. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 2008 181 : 746 755.
95. Miyara M, Amoura Z, Parizot C et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006 203 : 359 370.
96. Martin AG, Kleinhenz ME, Elmets CA. Immunohistologic identification of antigen-presenting cells in cutaneous sarcoidosis. J Invest Dermatol 1986 86 : 625 629.
97. Okamoto H. Epidermal changes in cutaneous lesions of sarcoidosis. Am J Dermatopathol 1999 21 : 229 233.
98. Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 2005 141 : 869 872.
99. Ueki H. Scar sarcoidosis can be an expression of the isomorphic response of Koebner against the scar. Kawasaki Med J 2001 27 : 67 73.
100. Sowden JM, Cartwright PH, Smith AG et al. Sarcoidosis presenting with a granulomatous reaction confined to red tattoos. Clin Exp Dermatol 1992 17 : 446 448.
101. Marcoval J, Mana J, Moreno A et al. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol 2001 137 : 427 430.
102. Ball NJ, Kho GT, Martinka M. The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol 2004 31 : 160 168.
103. Wahlström J, Dengjel J, Winqvist O et al. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin Immunol 2009 133 : 353 363.
104. Moller DR. Etiology of sarcoidosis. Clin Chest Med 1997 18 : 695 706.
105. Moller DR, Chen ES. What causes sarcoidosis? Curr Opin Pulm Med 2002 8 : 429 434.
106. Papadopoulos KI, Sjöberg K, Lindgren S et al. Evidence of gastrointestinal immune reactivity in patients with sarcoidosis. J Intern Med 1999 245 : 525 531.
107. Benoist C, Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2001 2 : 797 801.